Latest filing published 17 Oct 2012 for NUPATHE INC., €294k.
Insider track record
No signal scores available.
BioAdvance Ventures L P: trading record in brief
This profile gathers the share dealings of BioAdvance Ventures L P in Nupathe Inc. Between 11 August 2010 and 17 October 2012, the trades on record add up to 8 filings.
On the market, this insider has only sold: 3 sales, €573k in total. Since January 2012: no purchases and 3 sales on the market.
Most recently, on 17 October 2012, the filings show an open-market sale worth €294k in Nupathe Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to BioAdvance Ventures L P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 113,000 shares@ US$3.37Common StockSEC:0001192482-12-000232:0
- 72,407 shares@ US$3.29Common StockSEC:0001192482-12-000232:1
- 37,593 shares@ US$3.39Common StockSEC:0001192482-12-000232:2
- 286,116 sharesCommon StockSEC:0001209191-10-042445:0
- 205,763 sharesCommon StockSEC:0001209191-10-042445:1
- 529,849 shares@ US$10.00Common StockSEC:0001209191-10-042445:2
- 1,827,208 sharesCommon StockSEC:0001209191-10-042445:3
- 436,125 shares@ US$8.00Common StockSEC:0001209191-10-042445:4
8 of 8 declarations
